drugset / Trial / NCT05845645
A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B
RandomizedCrossoverQuadruple-blindBasic science
Summary
The purpose of the study is to estimate the relative bioavailability of 2 new UCB0599 formulations under elevated and normal gastric pH conditions in healthy participants (Part A) and to asess the safety, tolerability and pharmacokinetics of UCB0599 in healthy participants of Japanese and Chinese origins (Part B).
Timeline
- Start
- 2023-05-31
- Primary completion
- 2024-04-13
- Completion
- 2024-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | — | Oral |
| Subject | Minzasolmin | Small molecule | — | Oral |
Indications
No indication recorded.